跳至主要内容
临床试验/NCT06910046
NCT06910046尚未招募不适用

Ground-glass Opacity-dominant Peripheral Pulmonary Lesions Diagnosis Using Confocal Laser Endomicroscopy and Shape-sensing Robotic-assisted Bronchoscopy Guided Cryobiopsy: GLASS-CLEAR Study

Shanghai Chest Hospital1 个研究点 分布在 1 个国家目标入组 119 人开始时间: 2025年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
119
试验地点
1
主要终点
Diagnostic yield

研究概览

简要总结

The purpose of the study is to evaluate the diagnostic performance and safety of cryobiopsy for ground-glass opacity (GGO)-dominant peripheral pulmonary lesions (PPLs) under the guidance of shape-sensing robotic-assisted bronchoscopy (ssRAB) combined with confocal laser endomicroscopy (CLE). Additionally, the study aims to establish CLE interpretation criteria for GGO-dominant PPLs based on histopathological characteristics and validate the proposed criteria.

详细描述

This is a single-arm, single-center, and prospective study. Approximately 119 patients with GGO-dominant PPLs will be enrolled to undergo CLE and ssRAB-guided cryobiopsy for the diagnosis of lesions. During the procedure, CLE will be used to examine the lesion. The primary endpoint is the diagnostic yield of the procedure. The secondary endpoints include the diagnostic accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of the procedure, CLE interpretation criteria for GGO-dominant PPLs and its diagnostic efficacy in differentiating benign from malignant lesions, and the complication rate.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age≥18 years;
  • •Thin-slice chest CT showing GGO-dominant peripheral pulmonary lesions (diameter≥8mm, GGO component≥50%);
  • •Suspected pulmonary malignant tumor which requires transbronchial lung biopsy for diagnosis;
  • •Patients who have good compliance and sign informed consent.

排除标准

  • •Diffuse GGO, suspected of benign or infectious lesions;
  • •Preoperative imaging showing the target biopsy lesion adjacent to medium or large blood vessels;
  • •Patients with contraindications of bronchoscopy;
  • •Presence of concomitant endobronchial lesion during the bronchoscopy procedure;
  • •Pregnant or lactating women;
  • •Patients with known allergy for fluorescein;
  • •The investigators believe that patient has other conditions that are not suitable for the study.

研究组 & 干预措施

Patients with GGO-dominant peripheral pulmonary lesions

Experimental

Approximately 119 patients with GGO-dominant PPLs who meet the inclusion and exclusion criteria will be prospectively enrolled. CLE and ssRAB-guided cryobiopsy will be performed to diagnose the lesion.

干预措施: CLE and ssRAB-guided cryobiopsy (Diagnostic Test)

结局指标

主要结局

Diagnostic yield

时间窗: 1 year

Diagnostic yield is defined as the number of diagnostic lesions divided by the total number of lesions.

次要结局

  • Diagnostic accuracy(1 year)
  • Diagnostic sensitivity(1 year)
  • Diagnostic specificity(1 year)
  • Complication rate(1 month)
  • CLE interpretation criteria for GGO-dominant PPLs and its diagnostic efficacy in differentiating benign from malignant lesions.(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jiayuan Sun

Director, Department of Respiratory Endoscopy

Shanghai Chest Hospital

研究点 (1)

Loading locations...

相似试验